Molly V. Wagster - Concepedia

Author

Molly V. Wagster

Johns Hopkins University

Also Known As

M V Wagster, M. V. Wagster, M.V. Wagster, Molly V Wagster, Molly V. Wagster, Molly Wagster

Publications

11.1K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine National Institute on Aging National Institute of Neurological Disorders and Stroke National Institutes of Health

About

Molly V. Wagster is an author at Johns Hopkins University specializing in medicine, neuroscience, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	13	1.9K
2	Social Sciences	5	5	1.1K
3	Health Sciences	3	3	278
4	Natural Sciences	3	3	526
5	Public Health	2	2	76

Molly V. Wagster

Publications

10.3K

Citations

H-Index

Page 1

	Year	Citations
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Reisa A. Sperling, Paul Aisen, Laurel Beckett, Alzheimer s & Dementia	2011	7K
NIH Toolbox for Assessment of Neurological and Behavioral Function Richard Gershon, Molly V. Wagster, Hugh C. Hendrie, Neurology NeuropsychologyBrain FunctionMotor DifficultyCognitive RehabilitationSocial Sciences	2013	888
Widespread expression of Huntington's disease gene (IT15) protein product Alan H. Sharp, Scott J. Loev, Gabriele Schilling, Neuron	1995	514
Huntington's disease gene (IT15) is widely expressed in human and rat tissues S.-H. Li, Gabriele Schilling, W. Scott Young, Neuron Genetic DisorderNatural SciencesDisease GeneGeneticsRat Tissues	1993	342
The NIH Cognitive and Emotional Health Project Hugh C. Hendrie, Marilyn Albert, Meryl A. Butters, Alzheimer s & Dementia	2006	325
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging and the Alzheimer's Association workgroup Reisa A. Sperling, Paul Aisen, Laurel Beckett, Geriatric PsychiatryNeuropsychologyClinical SymptomsAgingPreclinical Stages	2011	198
Reductions in [ <sup>3</sup> H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease Peter J. Whitehouse, A. M. Martino, Molly V. Wagster, Neurology	1988	185
Frontal lobe volume in patients with Huntington's disease Elizabeth Aylward, N. B. Anderson, F. Bylsma, Neurology	1998	172
Expansion of polyglutamine repeat in huntingtin leads to abnormal protein interactions involving calmodulin. Jie Bao, Alan H. Sharp, Molly V. Wagster, Proceedings of the National Academy of Sciences Polyglutamine RepeatMolecular BiologyProtein GeneticsMolecular PharmacologyProtein Expression	1996	158
Expression of the Huntington's disease (IT15) protein product in HD patients Gabrlele Schilling, Alan H. Sharp, Scott J. Loev, Human Molecular Genetics	1995	105

Page 1